Oxford Nanopore Technologies (LON:ONT) Shares Down 3.7% – Time to Sell?

Oxford Nanopore Technologies plc (LON:ONT)’s share price was down 3.7% during mid-day trading on Wednesday . The company traded as low as GBX 111.90 and last traded at GBX 115.60. Approximately 58,115,211 shares changed hands during mid-day trading, an increase of 386% from the average daily volume of 11,970,034 shares. The stock had previously closed at GBX 120.10.

Analyst Ratings Changes

Separately, Royal Bank Of Canada reiterated an “outperform” rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of GBX 218.60.

Oxford Nanopore Technologies Stock Performance

The company has a market capitalization of £1.13 billion, a price-to-earnings ratio of -7.66 and a beta of 0.92. The company has a debt-to-equity ratio of 8.96, a current ratio of 3.56 and a quick ratio of 6.01. The stock has a 50 day simple moving average of GBX 123.03 and a two-hundred day simple moving average of GBX 128.25.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Nick Keher sold 22,993 shares of the stock in a transaction dated Tuesday, April 14th. The stock was sold at an average price of GBX 108, for a total value of £24,832.44. In the last quarter, insiders bought 22,799 shares of company stock valued at $2,578,133. Corporate insiders own 2.54% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.